RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties

← Drug Reference

Dexmedetomidine

Sedation of initially intubated and mechanically ventilated adult patients during..., Sedation of non-intubated adult patients prior to and/or during surgical and other...

High-alert medication

  • Moderate sedation agents, IV (class)

Indications

  • Sedation of initially intubated and mechanically ventilated adult patients during...
  • Sedation of non-intubated adult patients prior to and/or during surgical and other...

Adult dosing

  • icu sedation loading: dose: 1; unit: mcg/kg; route: IV; interval: over 10 minutes; weightBased: true; labelExcerpt: Initiate at one mcg/kg over 10 minutes , followed by a maintenance infusion of 0.2 to 0.7 mcg/kg/ hour .
  • icu sedation maintenance: dose: 0.2; unit: mcg/kg/hr; route: IV; interval: 0.2 to 0.7 mcg/kg/hour; weightBased: true; titrationTarget: Titrate to effect. Titrate to achieve the desired level of sedation; labelExcerpt: For adult patients : a maintenance infusion of 0.2 to 0.7 mcg/kg/ hour . The rate of the maintenance infusion should be adjusted to achieve the desired level of sedation.
  • procedural sedation loading: dose: 1; unit: mcg/kg; route: IV; interval: over 10 minutes; weightBased: true; labelExcerpt: Initiate at one mcg/kg over 10 minutes , followed by a maintenance infusion initiated at 0.6 mcg/kg/ hour and titrated to achieve desired clinical effect with doses ranging from 0.2 to 1 mcg/kg/ hour .
  • procedural sedation maintenance: dose: 0.6; unit: mcg/kg/hr; route: IV; interval: 0.2 to 1 mcg/kg/hr; weightBased: true; titrationTarget: Titrate to effect. Titrate to achieve desired clinical effect; labelExcerpt: For adult patients : the maintenance infusion is generally initiated at 0.6 mcg/kg/ hour and titrated to achieve desired clinical effect with doses ranging from 0.2 to 1 mcg/kg/ hour .

Pediatric dosing

  • Consult pharmacy/current label

Renal adjustment

  • Consult pharmacy/current label

Hepatic adjustment

  • Consider a dose reduction for patients with impaired hepatic function.

Contraindications

  • None

Clinical pearls

  • Continuous monitoring is required due to risk of bradycardia, hypotension, and sinus arrest.
  • Do not administer as an infusion lasting longer than 24 hours.
  • Use synthetic or coated natural rubber gaskets in administration components.
  • Consider reducing dose for geriatric patients and patients with hepatic impairment.

Source and review

  • DailyMed label (dexmedetomidine hydrochloride), Set ID 1faf1ac8-ff9b-4ed9-b562-06dab971173a, effective 2026-10-12. Last reviewed: 2026-11-11